Tom Gillingwater comments on new drug to combat children with spinal muscular atrophy

Press/Media: Expert Comment

Period6 Dec 2016 → 7 Dec 2016

Media coverage

8

Media coverage

  • TitleDrug might help some babies with rare, fatal disease
    Degree of recognitionInternational
    Media name/outletU.S. News & World Report (USA)
    Date7/12/16
    PersonsTom Gillingwater
  • TitleDrug shows promise for infants with rare, fatal muscle disease
    Degree of recognitionInternational
    Media name/outletUPI (USA)
    Date7/12/16
    PersonsTom Gillingwater
  • TitleRelief for babes with muscle wasting// a new agent can slow the progression of spinal muscular atrophy
    Degree of recognitionInternational
    Media name/outletDer Tagesspiegel (Germany)
    Date7/12/16
    PersonsTom Gillingwater
  • TitleRare disease: relief for babies with muscle wasting
    Degree of recognitionInternational
    Media name/outletPotsdam Latest News (Germany)
    Date7/12/16
    PersonsTom Gillingwater
  • TitleDrug might help some babies with rare, fatal disease
    Degree of recognitionInternational
    Media name/outletForeignAffairs.co.nz (New Zealand)
    Date7/12/16
    PersonsTom Gillingwater
  • TitleSpinal muscular atrophy drug shows more signs of efficacy
    Degree of recognitionInternational
    Media name/outletSign On San Diego (USA)
    Date6/12/16
    PersonsTom Gillingwater
  • TitleSpinal muscular atrophy drug shows more signs of efficacy
    Degree of recognitionInternational
    Media name/outletPharmacy Choice (USA)
    Date6/12/16
    PersonsTom Gillingwater
  • TitleDrug might help some babies with rare, fatal disease
    Degree of recognitionInternational
    Media name/outletHealth Day (USA)
    Date6/12/16
    PersonsTom Gillingwater